V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20160524 | 20061879 | 1.6 | 62 | Adjuvant (A) | 2019-03-05 | 2019-03-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101429376 |
| 20160526 | 20061880 | 1.54 | 56.3 | Adjuvant (A) | 2019-02-01 | 2019-02-12 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101810183 |
| 20160527 | 20061881 | 1.74 | 75.6 | Neo-adjuvant (N) | 2019-01-02 | 2019-01-16 | ECX | 02 | N | ECX | 101347868 |
| 20160528 | 20061882 | 1.65 | 92.4 | Adjuvant (A) | 2017-01-09 | 2017-01-13 | ECX | 02 | N | ECX | 101588422 |
| 20160529 | 20061883 | 1.57 | 51.6 | Neo-adjuvant (N) | 2016-08-12 | 2016-08-17 | ECX | N | null | ECX | 101585312 |
| 20160530 | 20061884 | 1.74 | 66.8 | Palliative (P) | 2019-07-09 | 2019-07-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101120186 |
| 20160534 | 20061885 | 1.66 | 75 | Neo-adjuvant (N) | 2018-10-09 | 2018-11-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100523787 |
| 20160535 | 20061886 | 1.76 | 45.85 | Palliative (P) | 2018-05-15 | 2018-05-15 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100156181 |
| 20160536 | 20061887 | 1.78 | 107.2 | Adjuvant (A) | 2019-04-04 | 2019-04-06 | ECX | null | N | ECX | 100503696 |
| 20160538 | 20061888 | 1.63 | 62.3 | Neo-adjuvant (N) | null | 2018-02-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101704952 |
| 20160540 | 20061889 | 1.63 | 64.7 | Neo-adjuvant (N) | 2017-11-05 | 2017-11-22 | ECX | N | N | ECX | 101022403 |
| 20160541 | 20061890 | 1.68 | 75.1 | Palliative (P) | 2018-08-07 | 2018-08-13 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100278481 |
| 20160542 | 20061891 | 1.72 | 89 | Adjuvant (A) | 2016-06-01 | 2016-06-24 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100656920 |
| 20160547 | 20061892 | 1.83 | 72.9 | Neo-adjuvant (N) | 2019-04-07 | 2019-04-08 | ECX | 02 | N | ECX | 100579610 |
| 20160549 | 20061893 | 1.82 | 72 | null | null | 2019-04-12 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100729105 |
| 20160550 | 20061894 | 1.68 | 64.7 | Palliative (P) | 2019-03-12 | 2019-03-29 | ECX | N | N | ECX | 101228867 |
| 20160552 | 20061895 | 1.77 | 82.6 | Adjuvant (A) | 2019-10-18 | 2019-10-30 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 101504865 |
| 20160553 | 20061896 | 1.7 | 73 | Adjuvant (A) | 2019-05-16 | 2019-05-17 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100528356 |
| 20160554 | 20061897 | 1.76 | 81.1 | Adjuvant (A) | 2018-02-11 | 2018-02-21 | ECX | N | N | ECX | 100879793 |
| 20160555 | 20061898 | 1.69 | 60.7 | Neo-adjuvant (N) | 2020-01-02 | 2020-01-31 | ECX | 02 | N | ECX | 101222903 |
| 20160556 | 20061899 | 1.66 | 58.8 | Adjuvant (A) | null | 2016-08-05 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 101793058 |
| 20160557 | 20061900 | 1.51 | 54 | Adjuvant (A) | 2017-09-18 | 2017-10-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100094173 |
| 20160558 | 20061901 | 1.53 | 89.2 | Adjuvant (A) | 2019-12-20 | 2019-12-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100537882 |
| 20160559 | 20061902 | 1.69 | 93 | null | 2019-02-15 | 2019-03-13 | ECX | N | N | ECX | 101338791 |
| 20160560 | 20061903 | 1.7 | 69.2 | Curative (C) | 2017-03-23 | 2017-04-12 | ECX | N | N | ECX | 101358577 |
| 20160561 | 20061904 | 1.53 | 89 | null | 2017-01-07 | 2017-01-24 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101517716 |
| 20160562 | 20061905 | 1.67 | 88 | Adjuvant (A) | 2017-08-12 | 2017-08-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100596538 |
| 20160565 | 20061906 | 1.7 | 79.1 | Neo-adjuvant (N) | 2017-12-12 | 2017-12-19 | ECX | N | N | ECX | 100949667 |
| 20160566 | 20061907 | 1.85 | 69.7 | Adjuvant (A) | 2016-08-15 | 2016-08-15 | ECX | 02 | N | ECX | 100455208 |
| 20160568 | 20061908 | 1.6 | 65 | null | 2018-07-02 | 2018-07-08 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101205113 |
| 20160570 | 20061909 | 1.62 | 79.1 | Neo-adjuvant (N) | 2019-01-25 | 2019-01-25 | ECX | 02 | N | ECX | 101450959 |
| 20160576 | 20061910 | 1.59 | 66.7 | Neo-adjuvant (N) | 2016-11-11 | 2016-11-19 | ECX | N | N | ECX | 101226222 |
| 20160577 | 20061911 | 1.74 | 80.1 | null | 2017-03-12 | 2017-03-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101446089 |
| 20160579 | 20061912 | 1.78 | 100.6 | Neo-adjuvant (N) | 2019-03-07 | 2019-03-07 | ECX | 2 | N | ECX | 101242423 |
| 20160580 | 20061913 | null | 45.5 | Curative (C) | 2019-09-02 | 2019-09-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100585781 |
| 20160581 | 20061914 | 1.61 | 50 | null | 2018-09-16 | 2018-09-20 | ECX | N | null | CAPECITABINE + GEMCITABINE | 100646877 |
| 20160582 | 20061915 | 1.71 | 91.8 | Curative (C) | 2016-12-16 | 2016-12-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100874203 |
| 20160583 | 20061916 | 1.74 | 54.9 | Neo-adjuvant (N) | 2017-11-02 | 2017-11-10 | ECX | N | N | ECX | 101614901 |
| 20160586 | 20061917 | null | 77 | Neo-adjuvant (N) | 2017-05-30 | 2017-06-08 | ECX | N | N | ECX | 101093548 |
| 20160587 | 20061918 | 1.56 | 73 | Neo-adjuvant (N) | 2018-02-02 | 2018-02-06 | ECX | 2 | null | ECX | 100549577 |
| 20160588 | 20061919 | 1.79 | 84 | null | null | 2017-11-11 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101631770 |
| 20160589 | 20061920 | 1.72 | 66.2 | Adjuvant (A) | 2017-12-22 | 2018-01-08 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100834127 |
| 20160590 | 20061921 | 1.78 | 75 | Neo-adjuvant (N) | 2017-10-25 | 2017-11-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100466314 |
| 20160591 | 20061922 | null | 88.4 | Adjuvant (A) | 2019-10-05 | 2019-10-06 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100878035 |
| 20160592 | 20061923 | 1.47 | 74.2 | Adjuvant (A) | 2016-05-06 | 2016-06-25 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100267152 |
| 20160593 | 20061924 | 1.7 | 87.8 | Neo-adjuvant (N) | 2018-11-15 | 2018-11-16 | ECX | N | N | ECX | 101290889 |
| 20160594 | 20061925 | 1.67 | 89.4 | null | 2018-07-03 | 2018-07-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100586254 |
| 20160595 | 20061926 | 1.74 | 72 | Palliative (P) | 2016-01-26 | 2016-01-26 | Gemcitabine + Capecitabine | N | N | ECX | 100843494 |
| 20160598 | 20061927 | 1.88 | 69.3 | Neo-adjuvant (N) | 2019-04-30 | 2019-04-30 | ECX | 02 | N | ECX | 101679515 |
| 20160600 | 20061928 | 1.82 | 59 | Neo-adjuvant (N) | 2018-12-20 | 2019-02-14 | ECX | N | N | ECX | 100663591 |